Form 4 for CRL Charles River Laboratories
Accepted 2022-02-24 00:00:00 ET · period of report 2022-02-22 · accession 0001127602-22-006654 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-02-24 | 2022-02-22+ | CRL | Smith David Ross | CFO, Corp. Executive VP | F - Tax | $291.50 | -715 | 20.7K | -3% | -$208.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-22 | F | D | 341 | $293.61 | 21,041 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-23 | F | D | 374 | $289.58 | 20,667 | D | — | — |